CPC13: Comparative study of p16, p53 and Ki67 immunostaining indicates that keratoacanthoma and cutaneous squamous cell carcinoma are clinicopathologically distinct entities
Shpadaruk, Volha Mesiano, Domenico Heffron, Cinthia Radonic, Teodora Wiggins, James Agrawal, Rishi Cheung, Elaine Slater, David
Shpadaruk, Volha
Mesiano, Domenico
Heffron, Cinthia
Radonic, Teodora
Wiggins, James
Agrawal, Rishi
Cheung, Elaine
Slater, David
Citations
Altmetric:
Affiliation
South Warwickshire University NHS Foundation Trust; University Hospitals Coventry and Warwickshire NHS Trust; Cork University Hospital, Ireland; Amsterdam UMC, The Netherlands; New Cross Hospital, Wolverhampton; Queen Elizabeth Hospital, Hong Kong; Chesterfield Royal Hospital; Gloucestershire Hospitals NHS Foundation Trust
Other Contributors
Publication date
2022-07
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Abstract for the British Association of Dermatologists 102nd Annual Meeting, 05–07 July 2022.
Citation
Shpadaruk V, Carr RA, Mesiano D, Heffron C, Radonic T, Wiggings J, Tso S, Agrawal R, Cheung E, Slater D, Craig P. Comparative study of p16, p53 and Ki67 immunostaining indicates that keratoacanthoma and cutaneous squamous cell carcinoma are clinicopathologically distinct entities. British Journal of Dermatology. 2022 Jul;187:25-.
Type
Conference Output